What is Aerodiagnostics?
Aerodiagnostics specializes in the diagnosis of gastrointestinal disorders, including Small Intestinal Bacterial Overgrowth (SIBO), fructose malabsorption, sucrose intolerance, and lactose intolerance. Leveraging state-of-the-art technology, the company offers non-invasive breath tests that facilitate accurate results and a high standard of customer service. Their model supports both patients and clinicians through convenient at-home sample collection and prompt analysis, aiming to streamline the diagnostic process for individuals experiencing digestive issues and provide essential support resources.
How much funding has Aerodiagnostics raised?
Aerodiagnostics has raised a total of $147K across 1 funding round:
Debt
$147K
Debt (2021): $147K with participation from PPP
Key Investors in Aerodiagnostics
PPP
Public-Private Partnership
What's next for Aerodiagnostics?
With the recent strategic investment and a substantial overall funding history, Aerodiagnostics is positioned for significant expansion. This late-stage funding context suggests a strategic focus on scaling operational capacity, enhancing technological capabilities, and potentially broadening its service offerings or geographic reach. The company is likely to invest in further research and development to maintain its competitive edge in the rapidly evolving field of diagnostic testing, solidifying its role as a key player in gastrointestinal health.
See full Aerodiagnostics company page
